The Effect of Goal-directed Therapy Guided by Stroke Volume Variation and Cardiac Index in Non-severe Surgical Patients
Fluid Therapy

About this trial
This is an interventional treatment trial for Fluid Therapy focused on measuring stroke volume variation, cardiac index, non-severe patients, gastrointestinal surgery
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) physical status of grade I-II
- Cardiac function classification by NYHA of grade I
without high risk factors according to the revised Lee cardiac risk index:
- High-risk type of surgery
- Ischemic heart disease
- History of congestive heart failure
- History of cerebrovascular disease
- Insulin therapy for diabetes
- Preoperative serum creatinine > 2.0 mg/dl
- undergoing gastrointestinal tumor surgery
Exclusion Criteria:
- Patients under 18 years or above 55 years
- patients with severe aortic regurgitation
- patients with permanent cardiac arrhythmias
- patients with intra-aortic balloon pump
- patients with severe pulmonary disease
- patients with hepatic or renal dysfunction
- patients undergoing emergency surgery
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Other
Experimental
group cardiac index
group Stroke Volume Variation
the treatment scheme of goal-directed fluid therapy(GDFT) use cardiac index(CI) as the primary judgment in group cardiac index,Patients in group cardiac index received a therapy with the goal of CI was no less than 2.5L•min-1•m-2 .
the treatment scheme of goal-directed fluid therapy(GDFT) use Stroke Volume Variation(SVV)and cardiac index(CI)as the primary judgment in group Stroke Volume Variation,Patients in group Stroke Volume Variation received a therapy with SVV was less than 12% and CI was no less than 2.5L•min-1•m-2 .